Blue Future Holding
Blue Future Holding is a Norway-based aquaculture investment holding company, wholly owned by EW Group, that builds and manages a portfolio of seven aquaculture businesses spanning fish genetics, diagnostics, ultrasound sorting technology, land-based farming infrastructure, vaccination equipment, salmon farming, and Spotted Wolffish production across Norway, Iceland, Latin America, and Southeast Asia.
- Company typePrivate
- Founded2018
- HeadquartersOslo, Norway
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Blue Future Holding does
Blue Future Holding AS is a privately held Norwegian investment company headquartered at Bolette Brygge 1 in Oslo, operating as the dedicated aquaculture investment vehicle of EW Group GmbH, a global conglomerate with 250 subsidiaries in animal and fish genetics, health, and nutrition. The company was established around 2018 and is staffed by 1-10 employees at the holding level, with operating activity concentrated in seven portfolio companies organized across three pillars: breeding, health and nutrition (GenoMar Genetics Group at 100% for tilapia breeding and distribution; Blue Analytics at 100% for diagnostics and genomics); innovative farming (Laxey at 10% for Icelandic land-based salmon targeting 27,000 mt by 2031; Aminor at 5% for the world's first commercial Spotted Wolffish facility); and technology and solutions (Greenfox Marine at 97% for ultrasound-based salmon gender sorting; Litus Akva at 55% for land-based aquaculture facility design; Lumic at 51% for vaccination equipment since 1991).
The underlying technology stack spans proprietary salmon and tilapia breeding programs, ultrasound sex-determination hardware, genomic diagnostics, RAS and hybrid flow-through facility engineering, and aquaculture vaccination machinery. The portfolio's geographic reach covers Norway (HQ and R&D), Iceland (Laxey farming), Latin America and Southeast Asia (GenoMar tilapia distribution), giving the group multi-region exposure to both hemispheres of aquaculture demand. The economic logic is to build a vertically integrated aquaculture platform covering genetics, health, farming infrastructure, and production.
Blue Future Holding generates revenue through investment returns and dividends from its wholly-owned and partially-owned subsidiaries rather than through direct product sales, pricing subscriptions, or licensing at the holding-entity level. The go-to-market is fundamentally portfolio-driven: each subsidiary runs its own commercial motion (Lumic sells equipment to Norwegian and international farms; GenoMar distributes juvenile tilapia to farmer networks across LATAM and SE Asia; Litus Akva designs and equips land-based facilities; Blue Analytics sells diagnostic and genomic services), with Blue Future Holding providing capital allocation, strategic guidance, and access to EW Group's proprietary genetic, health, and nutritional competencies. No public pricing, revenue figures, or ARR disclosures are available for the holding entity.
Blue Future Holding firmographics
Firmographics- Name
- Blue Future Holding
- Legal name
- Blue Future Holding AS
- Website
- https://bluefutureholding.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Blue Future Holding is a Norway-based aquaculture investment holding company, wholly owned by EW Group, that builds and manages a portfolio of seven aquaculture businesses spanning fish genetics, diagnostics, ultrasound sorting technology, land-based farming infrastructure, vaccination equipment, salmon farming, and Spotted Wolffish production across Norway, Iceland, Latin America, and Southeast Asia.
- Ownership category
- akta.pro rank
Blue Future Holding industry classification
Industry- Product category
- Aquaculture Investment Holdings
- NAICS
- Management of Companies and Enterprises (55111), Aquaculture (11251), Finfish Farming and Fish Hatcheries (112511)
- SIC
- Agricultural Prod-Livestock & Animal Specialties (200)
- akta.pro primary industry
- Aquaculture Breeding & Genetics Services (e.g., broodstock improvement) (AFAEAJAN)
- akta.pro secondary industries
- Aquaculture Health, Biosecurity & Veterinary Services (AFAEAAAK), Aquaculture & Fish Health Services (AFAEANAE)
Keywords
Where Blue Future Holding is headquartered
LocationHeadquarters
- HQ city
- Oslo
- HQ country
- Norway
- HQ region
- Europe
Offices1 record
Markets served
Blue Future Holding business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Investment Returns and Dividends: Blue Future Holding generates revenue through returns on investments in aquaculture companies, including dividends from wholly-owned and partially-owned subsidiaries across genetics, diagnostics, farming technology, and salmon production.
Marketing channels2 records
Blue Future Holding product offering
Product offeringCore offering
Blue Future Holding is an investment holding company dedicated to the aquaculture sector, wholly owned by the EW Group GmbH. It invests in, develops, and supports a portfolio of aquaculture-related businesses across three strategic focus areas: breeding, health and nutrition; innovative farming; and technology and solutions, with portfolio companies operating in fish genetics, biotech diagnostics, ultrasound technology, land-based aquaculture, vaccination equipment, salmon farming, and Spotted Wolffish production.
Product overview
Blue Future Holding is an investment company that operates as a portfolio of aquaculture-related businesses rather than a single unified product platform. The portfolio is organized around three core investment focus areas: breeding, health and nutrition; innovative farming; and technology and solutions. The company holds majority or significant stakes in seven portfolio companies spanning the aquaculture value chain: GenoMar Genetics Group (tilapia genetics and breeding/distribution), Blue Analytics (biotechnology diagnostics and genomics services), Greenfox Marine (ultrasound technology for fish feature identification and gender sorting), Litus Akva (land-based aquaculture facility design and equipment), Lumic (vaccination equipment for aquaculture), Laxey (land-based salmon farming), and Aminor (Spotted Wolffish production). As a subsidiary of EW Group (a global leader in animal and fish genetics, health, and nutrition with 250 subsidiaries worldwide), Blue Future Holding leverages EW Group's core competencies alongside its own seafood expertise and extensive network to drive sustainable growth and fish welfare in the aquaculture sector.
Differentiator
Problem solved
Functional benefit
Products and services
- GenoMar Genetics Group Portfolio company focused on selective breeding and genetic improvement programs for aquaculture species, including DNA-based breeding tools and genomic selection for farmed fish.
- Blue Analytics Portfolio company providing biotechnology diagnostics and genomics services, supporting aquaculture health management and genetic analysis.
- Greenfox Marine Portfolio company developing ultrasound technology solutions for monitoring and managing farmed fish in aquaculture operations.
- Litus Akva Portfolio company designing and delivering land-based aquaculture facilities, including Recirculating Aquaculture System (RAS) infrastructure for fish production.
- Lumic Portfolio company providing vaccination equipment and delivery systems used in fish health management across aquaculture operations.
- Laxey Portfolio company engaged in salmon farming operations, representing downstream aquaculture production within Blue Future Holding's portfolio.
- Aminor Portfolio company producing Spotted Wolffish, representing Blue Future Holding's non-salmonid aquaculture diversification investment.
Quantifiable outcome
- Targeting 27,000 mt annual salmon production within 2031 (via Laxey investment)
Companies that use Blue Future Holding
Customer profileSegments1 record
Ideal customer profiles1 record
Blue Future Holding technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Blue Future Holding partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered strong, core and minor.
- GenoMar Genetics GroupstrongAn international aquaculture breeding and distribution company providing genetically improved tilapia to farmers globally. Operations in Latin America and South-East Asia, with R&D in Norway. Blue Future Holding owns 100% of GenoMar Genetics Group.
- Blue AnalyticscoreA biotechnology company providing analytical services including diagnostics and genomics as a foundation for addressing biological challenges and improvements in aquaculture and agriculture industries.
- Greenfox MarinecoreA technology company applying high-resolution ultrasound to identify specific critical features on fish early in the life cycle. The company's first commercial application is gender sorting of juvenile salmon. Blue Future Holding owns 97%.
- Litus AkvacoreDesigns tailored land-based aquaculture facilities that optimize fish production and welfare. Provides equipment and expert guidance for efficient installations that maximize space, reduce operating costs, and lower energy consumption. Blue Future Holding owns 55%.
- LumiccoreAn innovative company developing, producing, and delivering vaccination equipment to the aquaculture industry since 1991, serving both Norway and international markets. Blue Future Holding owns 51%.
- LaxeyminorAn Icelandic salmon farming company based on the Westman Islands developing a hybrid flow-through land-based aquaculture operation using naturally filtered and heated sea water. Targeting 27,000 mt annual production within 2031. Blue Future Holding owns 10%.
- AminorminorThe world's first and only facility for Spotted Wolffish, produced on land. Controls the complete life cycle from egg to finished product. Blue Future Holding owns 5%.
Scale indicators1 record
Recent moves6 records
Expansion highlights6 records
Blue Future Holding competitors and assessment
Company assessmentDirect peers
- Salmon Evolution: Norwegian land-based salmon farming company using hybrid flow-through technology at its Indre Harøy facility. Directly comparable to Blue Future Holding's Laxey investment as a peer in the land-based salmon production thesis.
- Aqua-Spark: Dutch-based aquaculture-focused impact investment fund that builds a portfolio of sustainable aquaculture companies across the value chain. Most directly comparable as a multi-asset aquaculture investment vehicle with similar thesis around sustainable fish production.
- Akva Group: Norwegian aquaculture technology and equipment supplier (cages, feeding systems, sensors) serving salmon farmers globally. Comparable to Blue Future Holding's Litus Akva (land-based facility design) and Lumic (vaccination equipment) portfolio holdings.
- Benchmark Holdings: UK-listed aquaculture genetics, health, and nutrition investment holding company (Benchmark Animal Health / SalmoBreed / StofnFiskur). Closely parallels Blue Future Holding's breeding, health, and nutrition portfolio structure across multiple species.
- Andfjord Salmon: Norwegian land-based salmon farming company using flow-through technology at Kvalnes, Andøya. Direct peer to the Laxey investment in scaling land-based Atlantic salmon production.
Others
- AquaGen: Salmon genetics company that is itself an EW Group subsidiary, chaired by Blue Future Holding's Managing Director. Sits inside the broader EW Group aquaculture platform and is a portfolio-adjacent asset rather than a competitor.
Broad incumbents
- Cermaq: Global salmon farming company owned by Mitsubishi Corporation, with operations in Norway, Chile, and Canada. Broad incumbent comparable to the salmon production side of Blue Future Holding's portfolio.
- Mowi ASA: World's largest Atlantic salmon producer with integrated farming, processing, and feed operations. Broad incumbent relevant as the dominant customer/competitor context for Blue Future Holding's salmon and aquaculture technology portfolio.
- Pharmaq (Zoetis): Global aquaculture vaccines and health subsidiary of Zoetis, the world's largest animal health company. Comparable to the Lumic vaccination equipment and Blue Analytics diagnostics holdings as a broader incumbent in fish health.
Regional players
- Nordlaks: Norwegian family-owned salmon producer (and aquaculture technology investor via its Havfruene/NSG holdings). Operates in the same Norwegian aquaculture ecosystem as Blue Future Holding's portfolio companies.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Blue Future Holding social profiles
Digital presenceBlue Future Holding financial estimates
Financial estimateRevenue estimate
Valuation estimate
Blue Future Holding leadership team
Management profileNumber of profiles
Profiles4 records
Blue Future Holding subsidiaries and ownership
Company hierarchySubsidiaries7 records
Blue Future Holding funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Blue Future Holding M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Blue Future Holding
What does Blue Future Holding do?
Blue Future Holding is an investment holding company dedicated to the aquaculture sector, wholly owned by the EW Group GmbH. It invests in, develops, and supports a portfolio of aquaculture-related businesses across three strategic focus areas: breeding, health and nutrition; innovative farming; and technology and solutions, with portfolio companies operating in fish genetics, biotech diagnostics, ultrasound technology, land-based aquaculture, vaccination equipment, salmon farming, and Spotted Wolffish production.
Is Blue Future Holding a public or private company?
Blue Future Holding is a private company. It is classified as corporate owned and is currently operating.
When was Blue Future Holding founded?
Blue Future Holding was founded in 2018. It employs 1 to 10 people.
Where is Blue Future Holding based?
Blue Future Holding is headquartered in Oslo, Norway, in the Europe region.
How does Blue Future Holding make money?
One revenue line is on record: investment Returns and Dividends.
Who are Blue Future Holding's main competitors?
Direct peers on record are Salmon Evolution, Aqua-Spark, Akva Group, Benchmark Holdings and Andfjord Salmon. AquaGen is listed as an others. Broad incumbents are Cermaq, Mowi ASA and Pharmaq (Zoetis). Nordlaks is listed as a regional player.
Does Blue Future Holding have an API?
No public API is recorded for Blue Future Holding.
What industry is Blue Future Holding in?
Blue Future Holding's product category is Aquaculture Investment Holdings. Its primary akta.pro industry code is AFAEAJAN, Aquaculture Breeding & Genetics Services (e.g., broodstock improvement), with a secondary code of AFAEAAAK, Aquaculture Health, Biosecurity & Veterinary Services. Its NAICS code is 55111 and its SIC code is 200.